Medico Reumatólogo (UBA). ASAS and GRAPPA Reumatología del Hospital Italiano de La Plata. Diplomatura en Investigación: https://nitter.gq/t.co/f0ppJmXyNr
La Plata
Joined May 2013
- Tweets593
- Following353
- Followers432
- Likes1.5K
Rodrigo G Salinas retweeted
Research Article
Regional Trends and Patterns of Axial Spondyloarthritis in Latin America: A Study From the ESPALDA Registry (2019-2024)
📖 jrheum.org/cgi/content/full/…
@HOMILCOL @unisabana @londonojohn
#AxialSpondyloarthritis #LatinAmerica
Rodrigo G Salinas retweeted
Rheumatology Around the World 🌎
Establishing Centers of Excellence for Axial Spondyloarthritis in Latin America: Consensus Recommendations From the REAL-PANLAR Group
📖 doi.org/10.3899/jrheum.2025-…
@RodrigoGSalinas @italianolaplata @PedroSantosMor5 @BiomabAR
#Spondyloarthritis
It was a true honor to participate as a speaker at the @PPACMANgroup meeting in New York 🗽 , sharing our experience in the diagnosis and comprehensive evaluation of patients with psoriatic arthritis (#PsA).
Rodrigo G Salinas retweeted
NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @PanlarLeague
Free to read with registration on lancet.com
Proud to share our new paper on the pre-RA stage just published @seminarthrheum 📄
“Progression from seropositive arthralgia to rheumatoid arthritis: One-year predictors from a large cohort in the Reuma-Check program.”
Honored to share that I’ve been invited as a speaker at the 9th PPACMAN Annual Meeting in New York City on December 18, 2025 🗽
👉 “Arthralgia with Risk of Progression to Psoriatic Arthritis: Lessons from Reuma-Check”
@PPACMANgroup #PsA
An Honor be part @PanlarLeague
NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @PanlarLeague
Free to read with registration on lancet.com
Thank you was an a real team work, @jrheum
Now published in our new section: Rheumatology Around the World 🌍
Toward Harmonized Recommendations for Psoriatic Arthritis: A Comparative Viewpoint on Global Guidelines
📖 doi.org/10.3899/jrheum.2025-…
@Dr_AndreRibeiro @RodrigoGSalinas @HCPA_ @italianolaplata
#PsoriaticArthritis
Rodrigo G Salinas retweeted
CONGRESS | #ACR25 | PRESENTATION
Rodrigo Garcia-Salinas, Hospital Italiano La Plata, discusses findings from a prospective longitudinal cohort study investigating the therapeutic approach in patients with arthralgia at risk of progression to #PsA (ARP-PsA; N = 119).
A total of 44% of patients with ARP-PsA initiated treatment with NSAIDs (50%), csDMARD (48%), and corticosteroids (1%). Among these, 36% of patients met at least one high-risk criterion, with 60% receiving csDMARD (p = 0.04). At 1 year, 29% of patients developed PsA, of whom 62% were receiving csDMARD (p = 0.002).
Follow our live feed for more updates: loom.ly/HoxlbLs
Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website.
#Psoriasis #PsoriaticArthritis #MedEd #MedicalCongress #RheumTwitter @italianolaplata
Rodrigo G Salinas retweeted
🔬 New study by Dr. Rodrigo García Salinas et al.
💡D2M-#axSpA affects ~ 9% of patients in real-world clinical practice.
🧩Clinical and structural predictors such as psoriasis, smoking and joint damage are associated with D2M.
🧪Articular US is a key tool for identifying high-risk patients.
📖rdcu.be/eB76f
Toward Harmonized Recommendations for Psoriatic Arthritis: A Comparative Viewpoint on Global Guidelines jrheum.org/content/early/202…
Rodrigo G Salinas retweeted
Late-Onset #AxSpA (lo-axSpA): A Distinct Subgroup?
👉rdcu.be/d9uzU
📊 Key findings from the Reuma-check cohort:
✔️ 28% of axSpA cases started at ≥45 years.
✔️ More common in females (51%) & psoriasis (42%).
✔️ Lower NSAID response (52%) & HLA-B27 positivity (32%).
✔️ Shorter diagnosis delay (40 vs. 93 months) than early-onset axSpA
⚠️ lo-axSpA may require distinct diagnostic & treatment approaches.
doi.org/10.1007/s10067-024-0…
Rodrigo G Salinas retweeted
🚀 ¡Un curso imperdible como apertura de PANLAR 2025! El SPARTAN–PANLAR axSpA Pre-congress Educational Course es la mejor manera de iniciar el evento reumatológico del año.
👉 Descubre todo lo que necesitas saber deslizando y prepárate para una experiencia educativa única.
🔥 ¿Qué tan desafiante crees que será este taller? Cuéntanos en los comentarios cuántos 🌶 le das y asegura tu lugar en este imperdible curso.
🌟 ¡Reserva tu cupo ahora y sé parte de PANLAR 2025!
congreso-panlar.com/trabajos…
.
#PANLAR2025 #YoVoyAPANLAR
Rodrigo G Salinas retweeted
✅ Queremos compartir la noticia del registro #ESPALDA. Contamos con información de más de 400 pacientes con #Espondiloartrtitis Axial
✅Datos de países de #AmericaLatina para generar datos en la región
Gracias a investigadores locales @PanlarLeague @RodrigoGSalinas @FerSommer
Rodrigo G Salinas retweeted
Un gran equipo de expertos, apasionados reumatólogos reportando para @reumatimes en el American College of Rheumatology 2024 #ACR2024 #reumatimes
Es un orgullo y un placer anunciar para toda América el “SPARTAN-PANLAR axSpA pre-Congress educational course” una iniciativa de @PanlarLeague y @SPARTAN_Updates
Thank you for share our research @italianolaplata
Psoriasis pts w/ Arthralgia referred for Rheum Eval - 1419 referred pts, 8.4% (119) met at risk for PsA criteria, and 29% (35) developed PsA w/in 1yr. Predictors included +FHx PsO, Ultrasound synovitis or enthesopathy findings, & low tender joint count. buff.ly/3YIlmXs
Gracias por la invitación @redasopan
GAfPA's Dr. @RodrigoGSalinas will present a virtual session tomorrow at 10 AM Argentina time, during the meeting of the Alliance of Patient Organizations in Latin America, to explore the critical importance of achieving #remission in rheumatic diseases. This session will be conducted in Spanish.
Tune in here: bit.ly/4e077S6
Gracias por la difusión
¿Cuántos pacientes con artralgias sospechosas acaban teniendo una artritis psoriásica? El nuevo estudio de @RodrigoGSalinas et al. nos lo aclara 👌🏻 Acceso cerrado 🔒 academic.oup.com/rheumatolog…
